Immunome, Inc. - Neraca (Quarterly)

Immunome, Inc.
US ˙ NasdaqCM ˙ US45257U1088

Talaan ng Balanse (Quarterly)

Neraca Immunome, Inc. menunjukkan saldo akun perusahaan pada titik waktu tertentu. Data Neraca meliputi Aset, Aset Lancar, Aset Tetap, Properti, Pabrik dan Peralatan (PPE), Persediaan, Aset Tak Berwujud, Kewajiban, Kewajiban Lancar, Utang, Kewajiban Sewa Modal, Saham Biasa, Laba Ditahan, Saham Perbendaharaan, dan Ekuitas Pemegang Saham.

Semua angka adalah kelipatan 1,000,000.00 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Cash 7 40 36 60 56 49 43 35 27 20 44 38 91 99 270 165 156 143 258 144
Change (%) 489.65 -8.78 64.93 -5.99 -12.47 -12.90 -19.19 -21.85 -24.95 118.59 -13.52 135.95 8.87 173.33 -38.70 -5.91 -7.85 79.71 -44.15
Assets Current 7 43 41 63 61 57 46 38 29 23 47 40 91 145 313 284 244 221 323 277
Change (%) 473.22 -4.17 52.81 -2.59 -7.44 -18.25 -18.80 -22.23 -22.54 105.47 -15.06 131.28 58.29 116.53 -9.27 -14.16 -9.30 45.99 -14.14
Assets 12 45 43 64 63 58 48 39 31 24 48 41 93 149 320 296 257 240 343 296
Change (%) 271.57 -4.34 50.59 -2.47 -7.41 -17.60 -18.25 -21.72 -21.28 100.09 -13.88 124.84 59.44 115.26 -7.36 -13.27 -6.48 42.65 -13.54
Liabilities 6 3 5 4 8 10 10 9 7 7 34 32 87 29 34 42 42 59 36 27
Change (%) -43.50 48.11 -25.18 120.35 25.43 1.17 -11.28 -14.64 -0.92 363.30 -6.29 171.32 -67.09 19.28 23.97 -0.91 40.68 -39.79 -24.03
Equity 6 41 38 61 55 48 38 30 23 17 14 9 6 120 286 254 215 181 307 269
Change (%) 550.59 -8.37 60.01 -9.61 -12.06 -21.40 -20.06 -23.76 -27.86 -16.76 -32.64 -34.93 1,873.04 138.21 -11.11 -15.34 -15.70 69.53 -12.33
Liabilities And Stock Equity 12 45 43 64 63 58 48 39 31 24 48 41 93 149 320 296 257 240 343 296
Change (%) 271.57 -4.34 50.59 -2.47 -7.41 -17.60 -18.25 -21.72 -21.28 100.09 -13.88 124.84 59.44 115.26 -7.36 -13.27 -6.48 42.65 -13.54

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista